These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7581219)

  • 1. Bromocriptine and suppression of postpartum lactation. The incidence of adverse cardiovascular effects in women of child-bearing age.
    Herings RM; Stricker BH
    Pharm World Sci; 1995 Jul; 17(4):133-7. PubMed ID: 7581219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of bromocriptine versus breast binders as inhibitors of postpartum lactation.
    Shapiro AG; Thomas L
    South Med J; 1984 Jun; 77(6):719-21. PubMed ID: 6729548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical commentary: the bromocriptine (Parlodel) controversy and recommendations for lactation suppression.
    Rayburn WF
    Am J Perinatol; 1996 Feb; 13(2):69-71. PubMed ID: 8672187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ask the experts. Is suppression of lactation in postpartum patients still an indication for the use of bromocriptine mesylate (Parlodel)?
    Miller-Slade D
    AWHONN Voice; 1994 Nov; 2(11):11. PubMed ID: 7735182
    [No Abstract]   [Full Text] [Related]  

  • 5. Severe adverse effects of bromocriptine in lactation inhibition: a pharmacovigilance survey.
    Bernard N; Jantzem H; Becker M; Pecriaux C; Bénard-Laribière A; Montastruc JL; Descotes J; Vial T;
    BJOG; 2015 Aug; 122(9):1244-51. PubMed ID: 25761676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatal myocardial infarction associated with bromocriptine for postpartum lactation suppression.
    Dutt S; Wong F; Spurway JH
    Aust N Z J Obstet Gynaecol; 1998 Feb; 38(1):116-7. PubMed ID: 9521411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lactation suppression with bromocriptine.
    Hutchison P; Sill H
    N Z Med J; 1981 Oct; 94(694):309-10. PubMed ID: 7033847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of puerperal lactation by means of a single injection of bromocriptine retard.
    Valsamis J; Chavez H; Westelinck K; Haemers M; Francis G; L'Hermite M
    Eur J Obstet Gynecol Reprod Biol; 1987 May; 25(1):43-51. PubMed ID: 3595974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metergoline versus bromocriptine in the prevention of puerperal lactation. A double-blind clinical trial.
    Scapin F; Buonaccorsi S; Tronconi G; Pellicciotta G; Pontiroli AE
    Eur J Clin Pharmacol; 1982; 22(2):181-3. PubMed ID: 7047172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Convulsions due to a postpartum cerebral angiopathy associated with the administration of bromocriptine].
    Burckard E; Patrigeon RG; Felten D; Combourieu E; Escarment J
    Ann Fr Anesth Reanim; 2003 Jan; 22(1):46-9. PubMed ID: 12738020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lethal cardiovascular complications in patients receiving bromocriptine for ablactation.
    Iffy L
    Med Law; 1995; 14(1-2):99-104. PubMed ID: 7666753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative review of the tolerability profiles of dopamine agonists in the treatment of hyperprolactinaemia and inhibition of lactation.
    Webster J
    Drug Saf; 1996 Apr; 14(4):228-38. PubMed ID: 8713691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Puerperal hypertension, stroke, and seizures after suppression of lactation with bromocriptine.
    Katz M; Kroll D; Pak I; Osimoni A; Hirsch M
    Obstet Gynecol; 1985 Dec; 66(6):822-4. PubMed ID: 3840873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bromocriptine, lactation inhibition and drug monitoring].
    Fournié A; Graille V; Montastruc JL
    J Gynecol Obstet Biol Reprod (Paris); 1994; 23(2):129-30. PubMed ID: 8040567
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of lactation by a long-acting bromocriptine.
    Peters F; Del Pozo E; Conti A; Breckwoldt M
    Obstet Gynecol; 1986 Jan; 67(1):82-5. PubMed ID: 3940343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaginal bromocriptine in hyperprolactinemic patients and puerperal women.
    Jasonni VM; Raffelli R; de March A; Frank G; Flamigni C
    Acta Obstet Gynecol Scand; 1991; 70(6):493-5. PubMed ID: 1763616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cabergoline. A review of its pharmacological properties and therapeutic potential in the treatment of hyperprolactinaemia and inhibition of lactation.
    Rains CP; Bryson HM; Fitton A
    Drugs; 1995 Feb; 49(2):255-79. PubMed ID: 7729332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclothymic disorder and bromocriptine: predisposing factors for postpartum mania?
    Lake CR; Reid A; Martin C; Chernow B
    Can J Psychiatry; 1987 Nov; 32(8):693-4. PubMed ID: 3690486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe cerebral accidents postpartum in patients taking bromocriptine for milk suppression.
    Iffy L; Lindenthal J; Mcardle JJ; Ganesh V
    Isr J Med Sci; 1996 May; 32(5):309-12. PubMed ID: 8641870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bromocriptine mesylate for lactation suppression: a risk for postpartum hypertension?
    Watson DL; Bhatia RK; Norman GS; Brindley BA; Sokol RJ
    Obstet Gynecol; 1989 Oct; 74(4):573-6. PubMed ID: 2797633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.